| |
| |
|
| Insider
Information: |
Fyrwald J Erik |
| Relationship: |
Officer, Director |
| City: |
Indianapolis |
| State: |
IN |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
465,312 |
|
|
Indirect Shares
|
819,344 |
|
|
| Direct
Value |
$94,854,199 |
|
|
|
Indirect Value
|
$41,572,266 |
|
|
| Total
Shares |
1,284,656 |
|
|
| Total
Value |
$136,426,464 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
0
|
|
Stock
price went up :
|
2
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
2.0
|
0.0
|
| Percentage
Gain/Loss : |
 29.9%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Eli Lilly & Co |
LLY |
Director |
2023-12-18 |
71,886 |
|
0 |
Premium* |
|
|
Nalco Holding Co |
NLC |
Chairman, President, CEO |
2011-12-01 |
0 |
2008-03-07 |
0 |
Premium* |
|
|
Ecolab Inc |
ECL |
President |
2012-02-28 |
129,824 |
2012-02-28 |
49,402 |
Premium* |
|
|
Univar Inc. |
UNVR |
Chief Executive Office... |
2015-09-30 |
251,953 |
2015-09-30 |
735,514 |
Premium* |
|
|
Bunge Ltd |
BG |
Director |
2023-03-02 |
7,349 |
2023-03-02 |
23,138 |
Premium* |
|
|
International Flavors & Fragranc... |
IFF |
Officer, Director |
2024-02-06 |
4,300 |
2024-02-06 |
11,290 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
140 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 5 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BG |
Bunge Ltd |
Director |
– • – |
2020-12-02 |
4 |
GD |
$0.00 |
$0 |
I/I |
23,138 |
0 |
0 |
- |
|
| BG |
Bunge Ltd |
Director |
– • – |
2020-12-02 |
4 |
GA |
$0.00 |
$0 |
I/I |
23,138 |
23,138 |
0 |
- |
|
| BG |
Bunge Ltd |
Director |
– • – |
2021-03-02 |
4 |
A |
$79.16 |
$1,900 |
D/D |
24 |
3,826 |
0 |
- |
|
| BG |
Bunge Ltd |
Director |
– • – |
2021-05-05 |
4 |
A |
$88.40 |
$139,937 |
D/D |
1,583 |
5,409 |
0 |
- |
|
| BG |
Bunge Ltd |
Director |
– • – |
2021-06-02 |
4 |
A |
$88.77 |
$1,864 |
D/D |
21 |
5,430 |
0 |
- |
|
| BG |
Bunge Ltd |
Director |
– • – |
2021-09-02 |
4 |
A |
$77.62 |
$776 |
D/D |
10 |
1,601 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2021-11-15 |
4 |
A |
$258.43 |
$174,957 |
D/D |
677 |
68,564 |
0 |
- |
|
| BG |
Bunge Ltd |
Director |
– • – |
2021-12-02 |
4 |
A |
$85.71 |
$771 |
D/D |
9 |
1,610 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2022-01-18 |
4 |
A |
$247.07 |
$9,883 |
D/D |
40 |
68,842 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2022-02-22 |
4 |
A |
$239.13 |
$9,804 |
D/D |
41 |
68,883 |
0 |
- |
|
| BG |
Bunge Ltd |
Director |
– • – |
2022-03-02 |
4 |
A |
$107.37 |
$752 |
D/D |
7 |
1,617 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2022-03-21 |
4 |
A |
$289.64 |
$9,848 |
D/D |
34 |
69,170 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2022-04-18 |
4 |
A |
$298.82 |
$9,861 |
D/D |
33 |
69,203 |
0 |
- |
|
| BG |
Bunge Ltd |
Director |
– • – |
2022-05-12 |
4 |
A |
$0.00 |
$0 |
D/D |
1,842 |
3,459 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2022-05-16 |
4 |
A |
$299.38 |
$9,880 |
D/D |
33 |
69,236 |
0 |
- |
|
| BG |
Bunge Ltd |
Director |
– • – |
2022-06-02 |
4 |
A |
$114.57 |
$917 |
D/D |
8 |
1,850 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2022-06-21 |
4 |
A |
$297.34 |
$9,812 |
D/D |
33 |
69,497 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2022-07-18 |
4 |
A |
$321.77 |
$9,975 |
D/D |
31 |
69,528 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2022-08-15 |
4 |
A |
$313.94 |
$10,046 |
D/D |
32 |
69,560 |
0 |
- |
|
| BG |
Bunge Ltd |
Director |
– • – |
2022-09-02 |
4 |
A |
$100.05 |
$1,101 |
D/D |
11 |
7,325 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2022-09-19 |
4 |
A |
$305.09 |
$10,068 |
D/D |
33 |
69,807 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2022-10-17 |
4 |
A |
$332.76 |
$9,983 |
D/D |
30 |
69,837 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2022-11-21 |
4 |
A |
$361.17 |
$189,614 |
D/D |
525 |
70,362 |
0 |
- |
|
| BG |
Bunge Ltd |
Director |
– • – |
2022-12-02 |
4 |
A |
$96.50 |
$1,158 |
D/D |
12 |
7,337 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2022-12-19 |
4 |
A |
$357.78 |
$10,018 |
D/D |
28 |
70,581 |
0 |
- |
|
140 Records found
|
|
Page 5 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
